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Abstract: Infectious endocarditis (IE) is a very heterogeneous condition, which often requires surgical treatment. Even 
with surgical treatment, 30-day mortality rate can be high. A risk stratification is needed for the individual prognosis of the 
patient, but also for quality of care. Existing scores such as EuroSCORE II and STS scores do not include specific IE 
related parameters and give a poor assessment of the prognosis.  
A literature search was made in Web of Science for existing risk scores. The use of secondary references from 
comparative series proved to be necessary.  
Eight useful manuscripts could be identified in which a model was constructed. Two more comparative manuscripts are 
also found. Regression coefficients were mostly used to achieve this aim. However, there is considerable variation in 
study design, inclusion of patients and of risk factors. Definitions of risk factors and length of inclusion also vary. Five 
factors are of major importance: hemodynamic status, renal dysfunction, age, prosthetic valve infection and periannular 
involvement. In only one report medically treated patients are included which allows inclusion surgery itself as a factor.  
Hemodynamic status (including heart failure and need for mechanical support), renal dysfunction and age prove in most 
instances to be the dominant factors, but more specific IE related factors such as microbial data, Periannular 
involvement and cardiac damage should not be neglected. Because of the lengthy inclusion time, improvement of 
operative and postoperative care should be taken into consideration. These models have a potential value, but 
continuous recalibration, based on future international prospective data collection (such as in ICE-PCS) is necessary.  
Keywords: Infective endocarditis, Mortality, Risk score, Hemodynamic status, Renal dysfunction, Age.  
INTRODUCTION 
Infective endocarditis (IE) is a serious and 
heterogeneous condition [1-4] varying in clinical 
presentation and microbial agents. It can present as 
native (NVE) and prosthetic (PVE) valve IE, with or 
without cardiac and extra-cardiac complications. Its 
incidence has not diminished in the past 30 years [2]. 
This condition is the result of a complex interaction 
between the microorganism, its virulence and patient 
related factors, which include demographics and 
potential preexisting comorbidity. IE is becoming more 
prevalent in elderly patients with degenerative valve 
disease. A particular aggressive microorganism, 
Staphylococcus aureus, is also on the rise [2]. Surgery 
is often required to treat IE [2, 4-6]. Debridement of all 
necrotic and infected tissue and repair of cardiac 
damage often makes this a difficult and hazardous 
procedure. The indications are heart failure or 
hemodynamic instability, uncontrolled infection and risk 
for embolism [7]. In experienced centers, 30-day 
mortality could exceed 20% [2]. In urgent cases, this 
could even be 30% [5, 8]. This rate is higher than for 
any other surgical procedure on heart valves. 
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Moreover, the number of patients for any given center 
is small, leading to long inclusion times and slow 
learning curves, which adds to this problem. Rapid 
surgical decision-making concerning complex and 
potentially hazardous procedure with incomplete 
adequate clinical information is the most difficult aspect 
in dealing with patients with IE. Although the indication 
for surgery is becoming increasingly clear [1, 5], in 
some cases, microbial information is absent because 
cultures remain negative and some preexisting 
comorbid conditions might still be in the asymptomatic 
phase and therefore be undetected. An adequate 
scoring system leading to optimal patient selection, 
indication, timing and technique of surgery can be 
helpful herein [4]. Classic score systems such as 
EuroSCORE and STS systems are considered by most 
authors as neither specific nor accurate for IE [2-6]. 
These score systems lack the discrimination and 
calibration capacity for emergency cardiac surgery [3, 
8]. Predictive risk models should be accurate and easy 
to use by physicians. The research questions are: what 
are the available risk score systems for IE, how do they 
compare and what is their quality?  
METHODS 
A literature search was performed in PubMed and 
Web of Science, with the search terms “endocarditis 
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AND risk score”. Use of secondary references proved 
to be necessary. Absence of a multivariate analysis is 
an exclusion criterion. The Duke criteria are universally 
applied. Right-sided IE is excluded in most papers. The 
manuscripts are evaluated for their inclusion criteria of 
patients, design, statistical technique and construct of 
the model with validation and calibration techniques. 
This review focuses only on hospital or 30-day 
mortality, with one exception [9].  
RESULTS 
Using secondary references, eight papers could be 
selected. Seven of them investigate the 30-day 
mortality [1-6, 8]. One paper is focused on mortality at 
six months, and includes also medically treated 
patients. This allows the inclusion of surgery itself as a 
factor in the analysis as well as in the score model [9]. 
Two additional manuscripts make a comparison 
between some of these scores [7, 10]. Only the series 
based on the STS-IE score includes a large number of 
patients and is derived from the STS Adult Cardiac 
Surgery Database [2]. Another smaller series is derived 
from an ongoing multipurpose database and analyzes 
surgical patients with active IE for the RISK-E score [4]. 
One manuscript is derived from a prospective 
population-based observational study in 8 European 
centers, as members of the AEPEI association [8]. One 
older Brazilian small study includes a rather young 
population, in which rheumatic heart valve disease is 
more common and whose patients suffer from active IE 
[1]. For sake of homogeneity, another series includes 
only patients with NVE. Surgery has been considered 
urgent or emergent in over 90% of these patients [3]. 
One manuscript is based on 26 centers, but the sample 
is still rather small [5].  
Table 1 shows the size of the populations, the 
number of involved centers, the mean or median age, 
the hospital mortality, the percentage of NVE and 
active IE as well as the inclusion era. It is immediately 
obvious that there is a wide variation in these 
parameters, which makes comparison between the 
different scoring systems difficult. Specific risk factors 
could have an entirely different meaning in series with 
a low hospital mortality compared with those with a 
high mortality. Some findings are rather unexpected. 
One older Brazilian series with a relatively high 
mortality of 26.3% has a mean patient age of 33.9 
years [1] while in three other series with much older 
patients [55, 59 resp. 60 year] show a lower mortality, 
between 8.2 and 15.5% [2, 6, 8]. Table 2 shows the 
models, together with the area under the curve (AUC) 
which is helpful to estimate the discriminative power of 
the model. For the sake of simplicity, some parameters 
have to be grouped as stated previously [11]. It is also 
immediately clear that different series usually study 
different factors. Left ventricular factors including the 
hemodynamic status (such as emergent or urgent 
status), congestive heart failure (CHF), New York Heart 
Association functional class IV, need for intra-aortic 
balloon pump and need for mechanical ventilation be- 
cause of pulmonary edema, but also renal dysfunction 
Table 1: Characteristics of the Series 
Author (Ref N°) Score Name N Centers Hosp.mort (%) Age (y) NVE (%) Act IE (%) Era 
Gaca 2011 [2] STS-IE 13,617 824 8.2 55 (45-66) not stated 51.5 2002-2008 
Olmos 2017 [4] RISK-E 424 (D) 3 29.2 61+/- 14 60 100 1996-2014 
  247 (V)       
Gatti 2017 [8]  361 8 15.5 59+/-15 80.7 12.8 2000-2015 
Martinez 2014 [5]  437 26 24.3 61+/-15 61.1 100 2008-2010 
Da Costa 2007 [1] Da Costa 186 1 26.3 33.9 69.9 64.0 1988-1998 
De Feo 2012 [3] De Feo  440 1 9.1 49+/-16 100 83.0 1980-2009 
Di Mauro 2017 [6] Endoscore 2715 26 11.0 60+/-15 79.6 70.1 2000-2015 
Park 2016* [9]  4049 ICE-PCS 24.0 59 (45-72) 76.1 9.3 2000-2006 
  1197 ICE-PCS+ 28.6    2008-2012 
Varela 2017* [10]  18 1 26.8** 63+/-1 62.8 100 2002-2016 
D: development sample; hosp. mort: hospital mortality (or 30-day mortality); IE: infective endocarditis; N: number of patients; NS: not stated; NVE: native valve 
endocarditis; surg: surgery; V: validation sample. 
*The series of Park and Varela compare some of the score models and are not designed for the development of such model.  
**The series of Park 2016 shows mortality at 6 months and not at 30 days. 
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Table 2: Score for the Grouped Preoperative Factors  
Author  Gaca 2011 Olmos 2017 Gatti 2017 Martinez 2014 DaCosta 2007 De Feo 2012 Di Mauro 2017 Park 2016 
Reference N° [2] [4] [8] [5] [1] [3] [6] [9] 
Cardiac factors  
Card shock 17 15 1.1  5** 11***   
IABP 10        
Urgent surgery   1 1     
CHF/NYHA IV   1  5** 9  3 
Multiple valves 9    8    
Arrhythmia 8        
Prior CABG 7        
Prior valve surg. 7        
PVE  6  1 5**   1 
peri-ann  5  1 5** 5  2 
CD     5    
Veget > 10mm     4   1 
Non-cardiac complications of IE 
Renal dysf. 12 5 1.8   5  3 
Stroke        2 
TC-penia  7       
Demograhics and chronic disease 
Age  0/9/13/14*  1 4 5/7/9/11/13  0/2/3/4 
Female gender    1     
Diabetes  8/9        
COPD 5        
Hypertension 5        
ES>10    1     
Microbial related factors  
Sepsis  7   6    
Active IE 10        
Staphyloc    1    1 
virulent m-o  9       
Nosocomial        2 
Str. vir        -2 
Pos cult     5   2 
Diagn delay        -1 
Surgery        -2 
AUC 0.758 0.82 0.715 0.84 0.872 0.88 0.851  0.715 
* according age classes; ** CHF or shock; PVE or periannular abscess; *** mechanical ventilation for pulmonary edema or poor hemodynamic status 
Card: cardiogenic shock; CD: conduction defect; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; diagn delay: diagnostic delay 
(symptoms <1month before admission) dysf: dysfunction; ES: EuroSCORE; IABP: intra-aortic balloon pump; IE: infective endocarditis; m-o: microorganism; NYHA: 
New York Heart Association functional class; peri-ann: periannular complication (includes cardiac damage); pos cult.: positive culture; Staphyloc: staphylococcus; Str. 
vir: streptococcus viridans; surg: surgery; TC-penia: thrombocytopenia; veget: vegetation; 
NOTE: the orginal model of Gatti et al included also BMI >27 and systolic pulmonary artery pressure >55 mmHg as factors. 
NOTE: in the series of Park et al, about half of the patients underwent surgery, therefore surgical treatment could be included within the score and received a value of 
-2 and is protective. 
(with all possible definitions based on plasma 
creatinine or need for dialysis) and age, with all 
different age categories, are analyzed in most papers. 
Other IE-related parameters which are often scrutinized 
are PVE and periannular involvement (abscesses, 
fistulae and dehiscence of an infected valve 
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prosthesis). More common chronic comorbidity as well 
as gender are rarely included. Especially the 
hemodynamic factors, and particularly cardiogenic 
shock and need for mechanical support or for 
emergency surgery show high scores.  
Definitions of the variables under scrutiny are 
supplied by most authors [2-6, 8]. Sometimes, these 
definitions are based on those used in the EuroSCORE 
[6]. Then, the analysis leading to the model is usually 
performed in steps. First, a univariate analysis 
identifies the factors which have an effect on the 
outcome [1-4, 6, 8]. Second, the significant data are 
entered in a multivariate logistic regression analysis [1-
6, 8]. In the PALSUSE study, seven prognostic factors 
have a similar odds ratio, between 1.7 and 2.3. Each of 
these seven scores is assigned a value of “1” [5]. In 
one series, the odds ratios are used to calculate the 
items within the risk model [1]. Third, from the 
regression coefficients [2-4, 8], the scores themselves 
are derived mostly as integers. By adding these scores, 
the individual patients risk score can be calculated [1, 
2, 4, 5]. Most factors are binary, except age, which is 
sometimes categorized [3, 4]. Age is not always 
included in the analysis [2, 8]. Fourth, C-statistics is 
performed by plotting a Receiver-operating-
characteristic (ROC) curve and by determining the area 
under the curve (AUC) which serves as discriminatory 
power of the risk model [1-6, 8]. Sometimes, additional 
steps are taken. The internal (bootstrapping) and 
external validation [4, 6, 8] as well as calibration is 
performed by a second cohort of patients [9], or by 
comparing expected with observed mortality [2, 4]. An 
internal validation is absent in some series [1, 3, 5]. In 
one series, the 5-variable AEPEI model is compared 
with the 3-variable model by removing BMI and systolic 
pulmonary artery pressure as parameters. The latter 
parameter requires more complex measurement 
techniques, while BMI is not a part of the EuroSCORE 
II model [8]. In another series, the correlation with the 
EuroSCORE is determined by the Kendall’s tau test [3]. 
Goodness-of-fit is also tested in several series [3-5, 8]. 
Patients of the De Feo analysis are divided according 
the risk in four classes and predicted mortality is plotted 
against the score, using a one way analysis of variance 
and Bonferroni’s correction [3]. The possible effect of 
long inclusion times is taken into account by dividing 
the whole period in two episodes, thereby determining 
the specificity and sensitivity of the risk model [4]. A 
score system is not offered in one manuscript, although 
all statistical steps have been taken. Moreover, it is the 
only logistic model [6], while all other models are 
additive.  
Comparison with other recently developed IE-
specific and older scores has been performed, either 
by authors who developed their own score [4, 5, 8] or 
by others, who did not develop a model and can be 
considered as more “neutral” [7, 10]. Authors who 
developed their own risk model show superior results 
compared to the classic score such as the logistic 
EuroSCORE and EuroSCORE II [4]. A comparison 
between two of these scores [2, 3] with the more 
conventional EuroSCOREs is also made by these more 
“neutral” authors using their own series of IE patients. 
These series are also relatively small. The same 
analytical steps have been followed [7]. For hospital 
mortality, the model developed by De Feo [3] is the 
only one with an AUC above the level of 0.70. In 
contrast to models derived from the EuroSCORE and 
the STS database, the De Feo score relies heavily of 
IE-specific parameters. This could explain its success. 
However, with 3 predictors for 10/146 fatal events, the 
logistic regression in this comparative analysis seems 
over-fitted [7]. Nevertheless, need for inotrope 
medication or use of intra-aortic balloon pump and 
dialysis are well recognized predictors. The De Feo 
score has the additional advantage of its simplicity, but 
its applicability in PVE needs further investigation. 
Moreover, this score performs poorly in another very 
recently published comparative analysis [10]. This 
comparison includes also the STS-IE, PALSUSE, and 
Da Costa models. The sample of 180 patients is also 
relatively small, but it confirms the prognostic 
importance of age, hemodynamic status and renal 
dysfunction as well as of septic shock, but not of S. 
aureus. The steps taken in this analysis are aimed at 
determining the AUC for each model. The hospital 
mortality of 26.8%, however is much higher compared 
to analysis by Wang et al. [7]. The STS-IE and 
PALSUSE model show a relatively high AUC of 0.76 
(0.68-0.82) and 0.73 (0.66-0.79), and are comparable 
to that of EuroSCORE I and II, both with 0.74 (0.66-82), 
and STS score with 0.73 (0.63-0.84). However, the De 
Feo and Da Costa do significantly worse with AUC 0.68 
(0.58-0.76) and 0.65 (0.57-0.72) compared to the 
classic scores. Calibration with the Hosmer-Lemeshow 
test is only inaccurate for the Euroscore II, although the 
obsolete EuroSCORE I overestimates mortality 
considerably in the sample with an already high 
mortality of 26.8%. Involvement of multiple valve IE in 
one third of the sample could affect this result [10]. 
Both more comparative series differ in hospital 
mortality and in included scores, which makes drawing 
conclusions difficult, but for the moment, its seems that 
the models cannot be generalized. Moreover, the only 
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logistic and very recently developed Endoscore [6] is 
not involved.  
Remarkably, only two papers give explicitly causes 
of death, namely cardiogenic shock [1], low output 
syndrome, intractable arrhythmia, pulmonary 
embolism, multi-organ failure, persistent sepsis and 
pneumonia [3]. In two other papers, the postoperative 
complications are described extensively, which offer a 
clue for the causes of mortality [2, 5]. Other papers 
mention no causes [4, 6, 8]. Anyway, the score models 
are based on preoperative risk factors and not on the 
postoperative cause of mortality. Therefore, this 
information has no added value within this context.  
DISCUSSION 
The aim of the included papers is to provide an 
easy bed-side decision model for prognostic reasons 
[3, 6], for counseling of patients, decision making and 
comparative assessment for quality of care with 
benchmarking [2, 6, 8]. These models differ from the 
classic score models by inclusion of IE-specific 
parameters. The reason for the differences between 
the traditional and IE models might be the low 
incidence (1 to 2%) of IE in the series from which the 
EuroSCORE models were developed [6]. Even among 
patients with the highest scores, mortality does not 
exceed 30% in one model [2], hence potentially 
lifesaving surgery should not be denied in patients with 
high scores, especially since medical treatment alone 
carries a worse prognosis [5]. In one series, no patient 
was refused for surgery for the sake of risk [1]. The 
relative importance of each factor or component should 
be weighed within each model before an attempt of 
comparing the models can be made. The most 
important recognized risk factors are age, 
hemodynamic status (including signs of heart failure 
and dependence on mechanical support), renal 
dysfunction as well as cardiac damage or periannular 
involvement. Other factors such as gender, size of 
vegetation and microbial data are included in a 
considerably less degree.  
Age is considered as a universal predictor for a poor 
prognosis [5]. In some studies, age is dichotomized 
with a cut off at 40 [1], 60 years [2] or 70 years [5, 8]. 
Sometimes, age is given as categories [3, 4, 9]. In one 
series, age has not been identified as predictor [2]. In 
series with older patients, this factor receives high 
ranking [3, 4, 9]. These difference in approach makes 
comparison difficult between the models. Use of a 
threshold of 55 or 60 year as proposed in EuroSCORE 
and STS score systems seems also a reasonable 
option for IE specific models. The preoperative 
hemodynamic status in its broadest sense is not only 
an indication for surgery but also a powerful predictor 
for the 30-day mortality in IE and is almost universally 
recognized [1-5, 8]. Often, need for urgent or emergent 
surgery is already represented by critical conditions 
such as heart failure, need for mechanical circulatory 
support or shock. A comparable observation has also 
been made for more conventional cardiac procedures 
such as aortic valve replacement [12]. Nevertheless, 
surgery should not be withheld from patients with high 
risk, since satisfactory results still can be obtained. 
Renal dysfunction is another major predictor [2-4, 8, 9], 
and in some series the second most powerful predictor 
for 30-day mortality [2]. In one series, however, it could 
not be identified as predictor [1]. In another model, this 
predictor is indirectly included in the PALSUSE model, 
through the EuroSCORE [5]. This way of inclusion 
carries the risk of multiple collinearity. Moreover, acute 
renal dysfunction could be the marker a hemodynamic 
compromised status because of a decreased renal 
perfusion. The same remark can be made for need of 
mechanical ventilation, as result of pulmonary edema. 
Introduction of this factor in the model abolished the 
effect of “emergency” as predictor since all patients 
with mechanical ventilation were operated on 
emergency basis [3]. Arrhythmia as risk factor [1, 2] 
might also serve as marker for of impaired myocardial 
perfusion. It must be said, however that renal 
dysfunction [2-4, 8] and arrhythmia [1, 2] are included 
together with hemodynamic and left ventricular factors. 
This indicates that there is some independent effect, 
especially of renal function, on the outcome.  
PVE, periannular complications and cardiac 
damage are not always identified as a risk factor [6, 8]. 
Older series found an effect of PVE, and of conduction 
defects – as sign of cardiac damage – and 
echocardiographic complicated IE [1]. It could also be a 
marker of more virulent disease, more complex 
surgery, longer bypass and cross-clamp times, and 
hence higher mortality [3-5]. There is also an 
interaction with the expertise of the individual surgeon 
which is not easy to measure. The successful use of 
reparative techniques – if applicable – might serve as 
parameter, but this does not appear in any model. In 
any case, the change in incidence of aggressive 
microorganisms as cause for IE, as well as the change 
in approach and expertise make continuous 
recalibration of any model necessary. Septic shock has 
been labeled less powerful compared to cardiogenic 
shock in at least one series [4], but this is not a 
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universal observation. This finding should be treated 
with caution, since the degree of “sickness” can vary 
between population and the type of microorganisms 
has been included in only a few series [4-6]. Moreover, 
sepsis, or uncontrollable infection can be expected in 
complicated IE, with periannular extension of the 
infection. Thrombocytopenia has also been connected 
to uncontrolled infection and could have an impact on 
short-term outcome. However, “active IE” has not been 
identified as a risk [3]. The use of cardiac implants, and 
with it, the incidence of Staphylococcal IE are on the 
rise [2]. Microbial data are not provided by the STS 
database, but are important because of the 
aggressiveness of some microorganisms. Under 
representation of virulent microorganisms might lead to 
non-inclusion in score systems [1-3, 6, 8]. Positivity of 
the latest blood test sometimes replaces S. aureus as 
risk factor [3]. This might be related to need for early 
surgery but also to an unresolved IE. Furthermore, 
vegetation over 10mm has been identified as a risk 
factor for mortality, but only in two series [1, 9]. It 
carries the risk for embolization, but this risk decreases 
rapidly once an adequate antibiotic treatment has 
started. Recent preoperative stroke and preoperative 
cerebrovascular disease does not seem to be a 
contraindication for surgery [2, 4] and is identified as 
risk factor only at six months [9]. The practice of 
postponing surgery for IE in patients with stroke should 
be reexamined, especially since stroke and the risk for 
stroke is one of the indications for cardiac surgery. 
Nevertheless, in some series [4], surgery is less 
performed in patients with stroke.  
The limitations in the included papers are usually 
identified by the authors themselves. These have been 
highlighted extensively earlier [11]. Most studies are of 
observational and of retrospective nature. This makes 
the estimation of treatment policy before referral to a 
tertiary cardiac center, the referral policy itself, possible 
delay of diagnosis and consequently and timing of 
surgery difficult. All these issues can introduce a 
serious bias. Definitions differ between series, which 
complicates any comparison further. Small patient 
samples with consequently low number of variables 
within the model provide insufficient power for rather 
complex, heterogeneous and relatively infrequent 
diseases such as IE [3, 5, 8]. The smaller sample size 
and single center design make models less applicable 
in general. In some series PVE is excluded, the 
number of patients with healed IE is low and the 
urgency/emergency rate is high [3] which makes the 
series less representative for general application. In 
one paper, surgery was performed in 27% of the cases 
within the first 24 hours after diagnosis, which should 
be labeled as “emergent” [5]. In another series, urgent 
and emergent surgery was needed in over 90% of the 
patients [3]. This makes comparison between these 
series extremely difficult! Large databases are usually 
less detailed and are based on voluntary participation. 
Furthermore, the STS database does not make 
distinction between NVE and PVE and does not 
provide microbial data or data concerning periannular 
complications [2]. Not all scores are validated [3, 5]. It 
remains doubtful if external validation samples that are 
derived from expert tertiary cardiac centers will solve 
the problem. The composition of the patient sample 
determines which risk factors can be included within 
the model. Surgical treatment of active as well as 
healed IE allows the inclusion of active IE as a factor in 
the risk model. The same remark could be made for 
inclusion of right sided IE [3]. A major limitation is the 
patient group with surgical indication, but in which 
surgery is deemed too risky. In one paper, this is a 
considerable part of the population [4]. The exclusion of 
high risk patients could distort the whole model. In 
series, in which virulent microorganisms are 
underrepresented, this could lead to non-inclusion of 
this parameter in the risk score model [1-3, 8]. Last but 
not least, there are some statistical issues. Most scores 
models are additive, while there is a callout for logistic 
score [7], with the request to include regression 
coefficients and intercept. Only one paper provides 
such logistic model [6]. With c-statistics being 
performed, one should wonder if a discriminative power 
between 0.70 and 0.80 is high enough. Lastly, some 
factors are not so easy to disentangle: one example is: 
aggressive microorganism – PVE – cardiac damage – 
more hemodynamic instability and sepsis – more 
complex surgery with longer bypass time.  
CONCLUSIONS 
The risk scores for patients with IE should have a 
good discriminatory power and be user friendly. 
Besides the classic clinical risk factors, they should 
contain also IE-specific predictors of mortality such as 
virulence, inflammatory parameters, and IE related 
complications such paravalvular involvement, compro- 
mised hemodynamic status, renal dysfunction and 
chronic comorbid conditions such as diabetes. The risk 
score models should be useful in clinical decision 
making and comparison of the quality of healthcare 
facilities but should not be used to deny a possible 
beneficial treatment in more difficult patients. Even with 
high surgical risk, medical treatment alone would have 
a worse prognosis. These score, systems do not offer 
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exact selection criteria. This is all the more important 
since these scores are, although useful, imperfect and 
should be recalibrated continuously with the changing 
clinical presentation of IE. The development of a score 
system based on international prospective collection 
with uniform and clear definition of preoperative 
baseline parameters is highly desirable. This will allow 
inclusion of a large number of patients in a reasonably 
short time and allows construction of a model based on 
contemporary standards in pre, peri and postoperative 
care. With a large sample, under-representation of 
uncommon risk factors could be avoided. As temporary 
solution, comparisons should be made for all seven 
available score models, using contemporary 
multicenter series which are large and diverse enough.  
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